Name: UMIN ID:
Unique ID issued by UMIN | UMIN000030609 |
---|---|
Receipt number | R000034931 |
Scientific Title | Assessment of the safety of long-term nicotinamide mononucleotide (NMN) in healthy subjects; phase II study. The clinical trial to evaluate metabolic-syndrome-related parameters to develop NMN as Foods with Function Claims. |
Date of disclosure of the study information | 2017/12/29 |
Last modified on | 2023/07/07 15:48:48 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/12/28 13:53:19 | ||
2 | Update | 2017/12/29 15:18:05 | Date of disclosure of the study information |
|
3 | Update | 2018/01/05 09:47:31 | Organization |
|
4 | Update | 2018/05/28 17:28:52 | Anticipated trial start date |
|
5 | Update | 2018/06/28 15:41:50 | Name of person sending information Name of person sending information |
|
6 | Update | 2018/06/28 16:26:54 | Email |
|
7 | Update | 2018/09/10 18:05:42 | Narrative objectives1 Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
8 | Update | 2018/09/10 18:06:18 | Key exclusion criteria Key exclusion criteria |
|
9 | Update | 2018/09/10 18:07:38 | Anticipated trial start date |
|
10 | Update | 2018/12/25 12:54:31 | Anticipated trial start date |
|
11 | Update | 2019/12/31 14:09:33 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
12 | Update | 2019/12/31 14:15:07 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
13 | Update | 2020/05/14 11:18:46 | Other related information Other related information |
|
14 | Update | 2022/04/25 17:58:39 | Recruitment status Last follow-up date |
|
15 | Update | 2023/07/07 15:46:38 | Number of participants that the trial has enrolled |
|
16 | Update | 2023/07/07 15:48:48 | Recruitment status Last follow-up date |